R01 CA56060/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2003	1
2010	1
2011	1
2012	1
2013	1
2025	0

Page 1

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

Advani RH, Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ. Advani RH, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1374-9. doi: 10.1016/j.ijrobp.2010.07.041. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20934280 Free PMC article.

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.

Advani RH, Hoppe RT, Baer D, Mason J, Warnke R, Allen J, Daadi S, Rosenberg SA, Horning SJ. Advani RH, et al. Ann Oncol. 2013 Apr;24(4):1044-8. doi: 10.1093/annonc/mds542. Epub 2012 Nov 7. Ann Oncol. 2013. PMID: 23136225 Free PMC article. Clinical Trial.

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.

Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, Natkunam Y, Bartlett NL, Horning SJ. Ekstrand BC, et al. Blood. 2003 Jun 1;101(11):4285-9. doi: 10.1182/blood-2002-08-2644. Epub 2003 Feb 13. Blood. 2003. PMID: 12586628 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year